Neonatal alloimmune thrombocytopenia: Antenatal management
- 1 May 2000
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 182 (5) , 1233-1238
- https://doi.org/10.1067/mob.2000.104841
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Natural History of Fetomaternal Alloimmunization to the Platelet-Specific Antigen HPA-1a (PlA1, Zwa) as Determined by Antenatal ScreeningBlood, 1998
- Severe Neonatal Alloimmune Thrombocytopenia due to Anti‐HPA‐3aVox Sanguinis, 1998
- Feto‐maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids — more questions than answersBritish Journal of Haematology, 1998
- Fetal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1997
- Frequency of Immune Thrombocytopenia in Newborns: A Prospective StudyBlood, 1997
- Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulinAmerican Journal of Obstetrics and Gynecology, 1996
- Alloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesisAmerican Journal of Obstetrics and Gynecology, 1995
- Alloimmunization to the PIA1 platelet antigen: results of a prospective studyBritish Journal of Haematology, 1990
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- 348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1989